Replies to post #226699 on Biotech Values

[DewDiligence]

XERS acquires SBBP for $2.72/sh in stock—a 13% premium to Friday’s close:

https://www.businesswire.com/news/home/20210524005257/en

There is also a non-tradeable CVR worth up to $1/sh. The nominal deal value is $267M.